| Application no. and date | 09168970.3 (espacenet) (Federated) (European Patent Register), 20020520 | | Patent/reg. no. and date | DK/EP 2116259, 20120125 | | Publication date | 20091111 | | Priority no. and date | US 293343 P, 20010524 | | EP pub. no. and date |
EP 2116259 20091111 | | Effective date | | | Applicant/owner | ZymoGenetics, Inc., 1201 Eastlake Avenue East
Seattle, Washington 98102, US | | Applicant ref. no. | 11165-8 | | Inventor | Rixon, Mark W,
3724 248th Place SE
Issaquah, WA 98029, US,
Gross, Jane A,
4258 NE 74th Street
Seattle, WA 98115, US | | Representative | Marks & Clerk LLP, 44 rue de la Vallée
BP 1775
L-1017 Luxembourg, LU | | Opponent | | | IPC Class | A61K 39/395 (2006.01) , C07K 14/705 (2006.01) , C07K 16/00 (2006.01) | | Title | TACI-immunoglobulinfusionsproteiner | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | Udløbet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
